2011
Malignant Melanoma in Solid Transplant Recipients
Abstract: To determine malignant melanoma causespecific and overall survival among patients with melanoma diagnosed after organ transplantation compared with a national sample with malignant melanoma.
Search citation statements
Paper Sections
Select...
85
6
5
1
Citation Types
1
37
0
1
Year Published
Range
2012
2026
Publication Types
Select...
66
18
10
Relationship
1
93
Authors
Journals
Cited by 94 publications
(39 citation statements)
References 24 publications
1
37
0
1
Smart CitationsHow the paper below cites the one you are viewing
“…Our survival analysis supports a further role for immune response in controlling melanoma progression after clinical diagnosis. Transplant recipients had a three-fold increased risk of dying from their melanoma compared with melanoma patients without a transplant; this is generally consistent with most ( Vajdic et al , 2014 ; Brewer et al , 2011 ), but not all ( Matin et al , 2008 ), prior studies. The strong association for localized tumors – including for thin tumors with Breslow thickness <1 mm – implies that there may be subclinical spread of these tumors in transplant recipients, and in turn, that intact immune responses may normally prevent this spread.…”
Section: Discussion
supporting
confidence: 84%
Abstract